APH · Amphenol Corporation

Current Thesis

Amphenol Corporation’s artificial-intelligence interconnect thesis depends on recovering the $84.59 market reference level and delivering its third-quarter sales guidance at the 2026-10-28 earnings event before the $76 weekly support condition breaks. The operating evidence remains the 2026-07-29 results: orders of $10.7 billion, a book-to-bill ratio of 1.23:1, and third-quarter sales guidance of $9.3–9.4 billion. Book-to-bill compares orders received with sales recorded. Amphenol’s second-quarter results.

The September update changes the price assessment. The supplied adjusted daily series records a 2026-09-11 close of $83.92, a three-month gain of 9.3%, and a 14-period relative strength index (RSI) of 64.5; the 2026-08-28 reading was 39.0. These are measured improvements in momentum. The inference is that the recovery has strengthened, although the September close remains below the $84.59 recovery threshold identified in the 2026-08-30 research.

The narrative is maturing — the 2026-07-29 demand story remains the operating anchor, while CNBC’s 2026-09-01 Josh Brown spotlight and the completed September split have supplied newer attention. That classification does not establish crowding. The company now lists its third-quarter earnings event for 2026-10-28 at 1:00 p.m. Eastern, replacing the earlier calendar-only date attribution. Company event listing.

Bullish and bearish views on Amphenol Corporation

The model's bull view on Amphenol Corporation (APH), in brief: Orders exceed recorded sales. Amphenol reported $10.7 billion of orders and a 1.23:1 book-to-bill ratio on 2026-07-29. These figures support the demand-conversion thesis; third-quarter sales below the company’s $9.3 billion guidance floor would contradict its near-term operating… The bear view: Margin includes a discrete benefit. The 2026-07-29 release states that second-quarter operating income included an $80 million net tariff-recovery benefit. Third-quarter guidance excludes additional tariff recoveries, limiting the usefulness of the second-quarter 29.8% adjusted… Both cases follow in full.

Bull Case

• Orders exceed recorded sales. Amphenol reported $10.7 billion of orders and a 1.23:1 book-to-bill ratio on 2026-07-29. These figures support the demand-conversion thesis; third-quarter sales below the company’s $9.3 billion guidance floor would contradict its near-term operating premise. Second-quarter results.
• Organic demand supports headline growth. The 2026-07-29 release reported second-quarter sales growth of 55% in dollars and 30% organically. The organic figure establishes growth beyond acquisition contributions, although it does not isolate artificial-intelligence revenue. Second-quarter results.
• Price momentum has improved. On 2026-09-11, the supplied adjusted series placed the shares 4.8% below their $88.16 52-week high, with RSI at 64.5. A weekly close above the previously published $84.59 recovery threshold would confirm the price component of the thesis; a weekly close below $76 would invalidate it.

Bear Case

• Margin includes a discrete benefit. The 2026-07-29 release states that second-quarter operating income included an $80 million net tariff-recovery benefit. Third-quarter guidance excludes additional tariff recoveries, limiting the usefulness of the second-quarter 29.8% adjusted operating margin as a clean recurring benchmark. Second-quarter results.
• Analyst headlines need split context. TD Cowen maintained Hold on 2026-09-09 with a $90 target; the reporting service displays the preceding target as $175. Because Amphenol confirmed its two-for-one split in its 2026-09-04 filing, the nominal reduction alone does not establish deteriorating estimates. No split-normalized revision percentage is asserted. Analyst action, September filing.
• Attention does not establish participation. The supplied news dates CNBC’s Amphenol spotlight to 2026-09-01 and an options-alert headline to 2026-09-03. Neither supplies directional options exposure, ownership changes or fund flows. The sample is too small to support a crowding claim.

Setup & Price Structure

The public reference close is $83.92 on 2026-09-11, using the supplied split/dividend-adjusted series. The $84.59 recovery threshold and $76 June–August support reference come from the 2026-08-30 published analysis and were already expressed on the adjusted scale. The latest close is above support but below the recovery threshold; the split does not constitute a breakout.

The forecast is moderately favorable: the measured September momentum improvement supports a recovery case, while the unrecovered $84.59 level limits conviction. For this dossier, success requires a weekly close above $84.59 by the 2026-10-28 earnings event and reported third-quarter sales of at least the company’s $9.3 billion guidance floor, before invalidation. The supplied data contain no moving-average value, trading-volume series or current ownership measure, so distance above a rising average and expanding participation cannot be established.

Catalyst Calendar (next 30 days)

• 2026-09-22 — Dividend record date. Amphenol’s 2026-09-04 filing confirms a post-split quarterly dividend of $0.125 per share and this record date. This is a scheduled corporate event within the next month, with no direct test of interconnect demand. Company filing.
• 2026-10-28 — Third-quarter earnings event. Outside the next 30 days, the company-listed event at 1:00 p.m. Eastern is the thesis’s operating test: reported sales against the $9.3–9.4 billion guidance issued on 2026-07-29. The event listing confirms the earnings-event time, without establishing a separate release time. Company calendar.

What Would Change Our Mind

Loss of the June–August support reference would break the recovery structure: a weekly close below $76 on the adjusted series ends the thesis. This preserves the observable price condition published on 2026-08-30.

The operating premise also fails if third-quarter sales fall below the $9.3 billion floor of management’s 2026-07-29 guidance. Failure to record a weekly close above $84.59 by the company’s 2026-10-28 earnings event would end the time-limited recovery case even if the lower support reference remained intact. These are research conditions, with price recovery and revenue delivery both required for success.

Correlation Notes

The artificial-intelligence infrastructure connection is an exposure hypothesis, not a measured correlation. The 2026-08-30 research cited a 2026-07-28 optical/interconnect group reaction, but one episode cannot establish a stable relationship between Amphenol and its peers. The sample is too small to support a correlation claim.

This remains a single-name setup: the available September evidence supplies Amphenol’s 2026-09-11 price statistics and its company-specific earnings date, without a matched peer-return or participation series. Theme tags describe the interconnect thesis; they do not establish a synchronized group advance.